
Journal of the Chemical Society, Dalton Transactions p. 2713 - 2718 (1990)
Update date:2022-07-29
Topics:
Tsuchida, Eishun
Komatsu, Teruyuki
Hasegawa, Etsuo
Nishide, Hiroyuki
The both-faces-hindered and highly symmetric complexes 5,10,15,20-tetra(2',6'-dipivaloyloxyphenyl)porphyrinato-iron(II) and -cobalt(II), which have no amide residues but ester ones in the fence groups, have been synthesized.The iron(II) complex formed stable and reversible dioxygen adducts in toluene at 25 deg C.The half-life for irreversible oxidation is longer than 1 d.The ligation properties for this complex with imidazole derivatives or dioxygen have been determined and compared to those of one-face-hindered porphyrinatoiron complexes.The bulky groups on both sides of the macrocycle decrease the binding constants for imidazole and for dioxygen.The binding characteristics of an imidazole derivative, which is sterically restrained by the bulky groups, have been clarified by Moessbauer and i.r. spectroscopic measurements.A kinetic study of dioxygen association and dissociation suggests that the low oxygen affinity is brought about primarily by the high rate of ligand dissociation.
View MoreChangZhou XiaQing Chemical Co., Ltd.
Contact:+86-519-88721665
Address:3# Hengluo Road, Henglin Town, Changzhou City, Jiangsu Province,China
Zibo Ocean International Trade Co.,Ltd(expird)
Contact:+86 533 5160706
Address:1117, Hongtai Bld., Songling rd, Zichuan,Zibo,Shandong,China
HUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Doi:10.1002/(SICI)1099-0682(199807)1998:7<921::AID-EJIC921>3.0.CO;2-5
(1998)Doi:10.1016/S0040-4039(01)93859-6
(1989)Doi:10.1080/00397911003707212
(2011)Doi:10.3762/bjoc.7.51
(2011)Doi:10.1021/ac050851v
(2005)Doi:10.1246/bcsj.38.704
(1965)